Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.8195
+0.0195 (2.44%)
Apr 1, 2025, 9:40 AM EDT - Market open
Bone Biologics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Bone Biologics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Bone Biologics.
Recommendation Trends
Rating | Jan '23 | Feb '23 | Mar '23 | Apr '23 |
---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
EF Hutton | EF Hutton | Strong Buy Reiterates $540 | Strong Buy | Reiterates | $540 | +65,793.84% | Apr 13, 2023 |
EF Hutton | EF Hutton | Strong Buy Reiterates $540 | Strong Buy | Reiterates | $540 | +65,793.84% | Apr 3, 2023 |
EF Hutton | EF Hutton | Strong Buy Initiates $540 | Strong Buy | Initiates | $540 | +65,793.84% | Oct 18, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.99
from -4.83
EPS Next Year
-2.01
from -1.99
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | n/a | n/a |
Avg | n/a | n/a |
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -2.05 | -2.07 |
Avg | -1.99 | -2.01 |
Low | -1.91 | -1.93 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.